Note: Only FDA-approved drugs can be “prescribed,” which is why the term “recommendation” is used when talking about medical marijuana.
If marijuana is reclassified, it could also become available without a prescription, which could mean that medical marijuana patients may possibly end up purchasing their medication from the same dispensaries as recreational marijuana users. Health insurance likely wouldn’t pay for medical cannabis under those conditions; however, if it is reclassified and sold as an over-the-counter (OTC) drug, cannabis might be eligible to be paid for using a health savings or flexible spend account.
As insurance provider Cigna explains:
As always, CannaMD will keep you updated with the latest news and developments!
In the United States, however, it is expected to be years before medical marijuana is approved as a drug by the FDA, and before that happens, it is unlikely that insurance companies will add it to the list of drugs they cover. That being said, the ever evolving medical cannabis market has seen a number of unprecedented legal developments that could alter the course of this projection quickly and dramatically.
The extended health-care benefit will be optional, standalone coverage for plan sponsors, providing reimbursement for fresh and dried cannabis, as well as cannabis oil. Plan sponsors will have the option of an annual maximum coverage amount.
Coverage will be considered for conditions based on Canadian family physician guidelines, including for patients suffering from chronic neuropathic pain, refractory pain in palliative cancer care, nausea and vomiting due to chemotherapy and spasticity in multiple sclerosis or spinal cord injury.
Medavie Blue Cross is adding medical cannabis coverage to its benefits provision.
To be eligible for reimbursement, plan members will have to be pre-authorized, noted the release.
“Cannabis is a complex substance unique in the health benefits landscape,” stated the release. “It is not considered a prescription medication by Health Canada and does not meet typical requirements to be eligible for coverage under a prescription drug plan. Medavie Blue Cross will continue to monitor the latest clinical evidence and emerging trends to assess the new benefit on an ongoing basis.”
And not because they're great guys who want to pay more.
What is it (in the eyes of the government)?
If you can use CBD to adequately address psoriasis at $100/month versus one of the many autoimmune medications at $5000/month, which one do you think the health insurance carriers will go with?
How does health insurance treat it.
To be safe, HSA's reimburse for substances prescribed by a doctor.
It came to people’s attention via a girl, Charlotte Figi who had horrific seizures (multiple per day).
What about its legality?